Chronic Liver Disease Foundation and Walgreens to Launch Hepatitis C Testing Campaign

CLDF to Support Free HCV Testing at 60 Walgreens Stores across the U.S.

CLARK, N.J., May 19, 2015 /PRNewswire/ -- The Chronic Liver Disease Foundation (CLDF) announced today that it's collaborating with Walgreens to offer free hepatitis C (HCV) testing with the OraQuick® HCV Rapid Test at more than 60 Walgreens retail pharmacies in 12 major cities throughout the country.

The program, which is slated to launch this August and run through January 2016, will offer free rapid HCV testing on specific days and times each week to patients at risk for HCV. Rapid testing and patient education will be conducted by trained healthcare professionals on site at each retail location and individuals who test positive will be linked directly to one of CLDF's 75 Hepatology Centers of Expertise throughout the U.S.

"The rapid hepatitis testing program demonstrates our commitment to helping patients access important information that can help to improve their health," said Glen Pietrandoni, RPh, AAHIVP, senior director, virology, Walgreens. "We are proud to collaborate with the Chronic Liver Disease Foundation on this initiative. Through this testing program we can help people become educated on the risk factors, identify people infected with HCV and help them get linked to appropriate care."

"Today, approximately 5.2 million Americans have hepatitis C and the vast majority does not know it," said Dr. Willis C. Maddrey, President of the Chronic Liver Disease Foundation. "However, new therapies are now available that can effectively treat and cure hepatitis C.

Each year, about 17,000 Americans become infected with hepatitis C. Up to 75 percent of people with chronic hepatitis C infection were born during 1945-1965, and up to three out of four people infected with hepatitis C are unaware of their infection.

OraQuick® HCV is the first and only FDA-approved and CLIA-waived point of care test for detection of HCV infection in at-risk individuals. The simple, accurate platform enables healthcare providers to deliver an accurate diagnosis in 20 minutes, using venipuncture or fingerstick blood.  The test is manufactured by OraSure Technologies OSUR, -0.16% in Bethlehem, Pa.
 
About the Chronic Liver Disease Foundation
Established in 2001, the Chronic Liver Disease Foundation is a nonprofit 501(c)(3) educational organization dedicated to providing hepatology related continuing medical education, news and information to healthcare professionals across the US. The CLDF is led by a Board of Trustees comprised of nationally renowned liver disease specialists. Furthermore, the CLDF believes that educational programs should be developed by the specialists who are actively involved in the research, treatment and management of a disease. As such the CLDF has developed a network of 75 Centers of Educational Expertise and multiple Advisory Boards who are actively involved in program creation related to specific disease topics which include; hemochromatosis, hepatic encephalopathy, hepatitis B, hepatitis C, hepatocellular carcinoma, HIV co-infection, liver transplantation and NASH/NAFLD. The CLDF's educational opportunities are offered in a variety of formats including an interactive web site, live meetings, teleconferences, print pieces, webcasts and other electronic mediums.  For more information, please visit www.chronicliverdisease.org.   

Media Contact:Contact:Alessandra LaMastro for CLDF973-668-8354alamastro@focusmeded.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/chronic-liver-disease-foundation-and-walgreens-to-launch-hepatitis-c-testing-campaign-300085539.html

SOURCE Chronic Liver Disease Foundation

Copyright (C) 2015 PR Newswire. All rights reserved

The SLO Hep C Project wants you to get tested

The month of May is Viral Hepatitis Awareness Month. The SLO Hep C Project wants you to get tested, and is now offering free hepatitis C testing throughout SLO County.

Kris Gottlieb, the finance support and communications coordinator for the SLO County Aids Support Network—which works in conjunction with the SLO Hep C Project—said it’s important to get the word out about the virus, who’s at risk, and what the symptoms are. He said a recently introduced bill could help spread the word.

AR 57, a bill recently introduced by state Sen. Bill Monning (D-Carmel) and Assemblymember Katcho Achadijan (R-SLO) would recognize May 19 as Viral Hepatitis Awareness Day in the county, with the aim of spreading awareness and understanding about the virus. Gottlieb said it’s a big deal on the local level.

Read more...

Mid-Mo Health Expo offers free health screenings

COLUMBIA — When the Missouri Hepatitis C Alliance held the inaugural Mid-Mo Health Expo last year at the Parkade Center, organizers envisioned a small health education fair for the community.

But when word got out that Boone Hospital Center was providing free health screenings, dozens came out to take advantage of the offer.

Sixty-seven participants received more than 300 screenings, said Aaron Boone, a development manager for the Missouri Hepatitis C Alliance.

Read more...

Hepatitis C testing resumes in Meigs

POMEROY — The Meigs County Health Department has resumed Hepatitis C testing.

The Meigs County Health Department has historically tested residents for Hepatitis C through a program funded by the Ohio Department of Health. However, ODH’s testing program ended last October due to lack of funding. As a result, the health department had to temporarily stop providing tests.

Having performed 24 tests in 2013 and 11 tests in 2014 before the program ceased, health department staff knew that they had to do what they could to continue providing tests. An overall view of 2014 data showed that Meigs County had 46 confirmed and 17 suspected cases of Hepatitis C.

Read more...

Seattle-HIV testing in ED serves as link to care

"SEATTLE — An HIV testing program in an ED, which was originally implemented to describe the local epidemic, played a significant role in linking individuals to care, according to data presented at CROI 2015".

“Over a 25-year period, the program evolved, and this change is partially evidenced by declining undiagnosed HIV infection, increased use of antiretroviral therapy, increased viral suppression and decline in HIV incidence,” Thomas C. Quinn, MD, of the National Institute of Allergy and Infectious Diseases, said during his presentation".

"Quinn and colleagues examined local trends in HIV and hepatitis C in the Johns Hopkins Hospital ED population for a 25-year period. They conducted 6- to 8-week identity-unlinked serosurveys in the ED in 1987, 1988, 1992, 2001, 2007 and 2013. The study included 18,144 eligible patients who required a blood draw for a medical reason. Excess sera were collected, and specimens underwent ELISA testing followed by Western blot (from 1992-2013). The specimens also were tested for HCV in 1988 and from 2001 to 2013".

Read More...